Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 76
• 16 sites in 6 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with advanced pancreatic, lung, breast or colorectal cancer that cannot be removed by surgery. It tests the safety and early effect of [177Lu]Lu-NNS309.

Age

18 years or older

Sex

All sexes can join.

Disease stage

Locally advanced and cannot be removed by surgery, or metastatic: pancreatic ductal adenocarcinoma, non-small cell lung cancer, breast cancer or colorectal cancer.

Read by machine on 9 Nov 2026.

Sites (16)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details